Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Current Cancer Drug Targets|March 28, 2019
Mutational Testing in Gastrointestinal Stromal TumorYu Wang, Jerry CallBMC Cancer|March 21, 2012
Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registryJerry Call, Christopher D Walentas, Jens C Eickhoff, et al.Journal of Gastrointestinal Cancer|December 1, 2009
Evaluation of self-reported progression and correlation of imatinib dose to survival in patients with metastatic gastrointestinal stromal tumors: an open cohort studyJerry Call, Norman J Scherzer, P David Josephy, et al.Cancer Investigation|May 5, 2023
Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) RegistryJerry Call, Jonathan Wojtkowiak, Denisse Evans, et al.Clinical Sarcoma Research|March 15, 2019
Genomic aberrations in cell cycle genes predict progression of <i>KIT</i>-mutant gastrointestinal stromal tumors (GISTs)Michael C Heinrich, Janice Patterson, Carol Beadling, et al.Cancer Research Communications|June 11, 2026
Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatmentHomma M Khosroyani, Alina Teuber, Ajia Town, et al.Pageof 1